Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975;286(4):413-28.
doi: 10.1007/BF00506655.

Dopamine-induced neurogenic vasodilatation in isolated perfused muscle preparation of the dog

Dopamine-induced neurogenic vasodilatation in isolated perfused muscle preparation of the dog

J L Willems et al. Naunyn Schmiedebergs Arch Pharmacol. 1975.

Abstract

Dopamine, injected into the lumbar aorta of the dog in doses which produce a reversible inhibition of synaptic transmission in the lumbar paravertebral ganglia (0.5-64x10-8 moles), produces a neurogenic vasodilatation in the isolated perfused hindleg or gracilis muscle. This was abolished by acute preganglionic decentralization and by administration into the perfused preparation of alpha-adrenoceptor blocking agents, but not of atropine or diphenhydramine. After decentralization, preganglionic electrical stimulation restored the dopamine-induced indirect vasodilatation. The neurogenic vasodilatation was also seen with intra-aortic injections of epinine (2-32x10-8 moles) and apomorphine (1.2-19.2x10-8 moles) and was preferentially blocked by haloperidol (0.26x10-6 moles). (-)-Noradrenaline, injected into the lumbar aorta in baroreceptor-denervated dogs, was found to be equipotent with dopamine in eliciting the neurogenic vasodilatation; this (-)-noradrenaline-induced effect was preferentially blocked by phentolamine (8x10-6 moles). The possibility that the neurogenic vasodilatation, which occurs upon intra-aortic injection of dopamine in the dog, is due to its gnaglionic-inhibitory effect is discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Physiol Rev. 1955 Jul;35(3):629-63 - PubMed
    1. Arch Int Pharmacodyn Ther. 1966 Feb;159(2):401-6 - PubMed
    1. Fed Proc. 1965 Nov-Dec;24(6):1298-310 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmakol. 1969;265(1):67-80 - PubMed
    1. Circ Res. 1962 Feb;10:156-60 - PubMed

MeSH terms